Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 6,201,000 | 5,825,000 | 3,239,000 | 1,722,000 | 89,000 |
Depreciation Amortization | 2,050,000 | 1,515,000 | 992,000 | 473,000 | 1,480,000 |
Income taxes - deferred | -116,000 | 243,000 | 3,000 | 71,000 | -214,000 |
Accounts receivable | 313,000 | 272,000 | 694,000 | 975,000 | -1,171,000 |
Accounts payable and accrued liabilities | -118,000 | -242,000 | -222,000 | -253,000 | 80,000 |
Other Working Capital | 489,000 | -1,325,000 | -872,000 | -409,000 | -1,638,000 |
Other Operating Activity | 2,565,000 | 1,891,000 | 1,092,000 | 31,000 | 9,542,000 |
Operating Cash Flow | $11,384,000 | $8,179,000 | $4,926,000 | $2,610,000 | $8,168,000 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -607,000 | -577,000 | -577,000 | -252,000 | 12,403,000 |
PPE Investments | -579,000 | -423,000 | -284,000 | -165,000 | -650,000 |
Net Acquisitions | -1,584,000 | -1,540,000 | -1,457,000 | -1,255,000 | -25,920,000 |
Purchase Of Investment | -380,000 | -332,000 | -301,000 | -279,000 | -455,000 |
Other Investing Activity | 19,000 | 19,000 | 0 | -91,000 | 7,000 |
Investing Cash Flow | $-3,131,000 | $-2,853,000 | $-2,619,000 | $-2,042,000 | $-14,615,000 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | N/A | N/A | 8,184,000 |
Debt Repayment | -4,750,000 | -3,750,000 | -1,250,000 | -1,250,000 | -2,500,000 |
Common Stock Issued | 169,000 | 157,000 | 100,000 | 88,000 | 256,000 |
Common Stock Repurchased | -546,000 | -497,000 | -352,000 | -309,000 | -1,583,000 |
Dividend Paid | -3,605,000 | -2,711,000 | -1,811,000 | -917,000 | -3,449,000 |
Other Financing Activity | -145,000 | -134,000 | -95,000 | -89,000 | -138,000 |
Financing Cash Flow | $-8,877,000 | $-6,935,000 | $-3,408,000 | $-2,477,000 | $770,000 |
Exchange Rate Effect | -35,000 | -26,000 | -3,000 | -23,000 | 43,000 |
Beginning Cash Position | 5,997,000 | 5,997,000 | 5,997,000 | 5,997,000 | 11,631,000 |
End Cash Position | 5,338,000 | 4,362,000 | 4,893,000 | 4,065,000 | 5,997,000 |
Net Cash Flow | $-659,000 | $-1,635,000 | $-1,104,000 | $-1,932,000 | $-5,634,000 |
Free Cash Flow | |||||
Operating Cash Flow | 11,384,000 | 8,179,000 | 4,926,000 | 2,610,000 | 8,168,000 |
Capital Expenditure | -579,000 | -423,000 | -284,000 | -165,000 | -650,000 |
Free Cash Flow | 10,805,000 | 7,756,000 | 4,642,000 | 2,445,000 | 7,518,000 |